InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

- Current share price for 4DX : $3.670

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,210 Quarterly Activity Report - Clarification 28 Oct 2022 9:30AM $0.640 $3.670 risen by 473.44%
$2,210 Quarterly Activity Report and Appendix 4C for Q1 FY2023 27 Oct 2022 9:39AM $0.670 $3.670 risen by 447.76%
$2,210 4DMedical releases CT LVAS in Australia 25 Oct 2022 9:10AM $0.610 $3.670 risen by 501.64%
$2,210 4DMedical progresses towards full reimbursement in the US 19 Oct 2022 9:36AM $0.580 $3.670 risen by 532.76%
$2,210 Change in substantial holding 13 Oct 2022 12:15PM $0.655 $3.670 risen by 460.31%
$2,210 Notification of Expiry of Unlisted Options 13 Oct 2022 8:58AM $0.670 $3.670 risen by 447.76%
$2,210 Notification of cessation of securities - 4DX 13 Oct 2022 8:50AM $0.670 $3.670 risen by 447.76%
$2,210 Notice of Annual General Meeting/Proxy Form 3 Oct 2022 8:57AM $0.580 $3.670 risen by 532.76%
$2,210 Appendix 4G and Corporate Governance Statement 30 Sep 2022 4:17PM $0.580 $3.670 risen by 532.76%
$2,210 2022 Annual Report 30 Sep 2022 4:16PM $0.580 $3.670 risen by 532.76%
$2,210 Notice of AGM Date and Director Nomination Closing Date 15 Sep 2022 9:52AM $0.640 $3.670 risen by 473.44%
$2,210 4DMedical Investor Presentation - September 2022 6 Sep 2022 8:49AM $0.670 $3.670 risen by 447.76%
$2,210 Vanderblit 'burn pit' trial hits primary endpoint 31 Aug 2022 9:10AM $0.500 $3.670 risen by 634%
$2,210 FY22 Full Year Results 19 Aug 2022 10:04AM $0.645 $3.670 risen by 468.99%
$2,210 Appendix 4E - Preliminary Final Report 19 Aug 2022 10:02AM $0.645 $3.670 risen by 468.99%
$2,210 Amended Quarterly Activity Report & Appendix 4C - Q4 FY2022 26 Jul 2022 9:41AM $0.590 $3.670 risen by 522.03%
$2,210 Quarterly Activity Report and Appendix 4C for Q4 FY2022 25 Jul 2022 9:49AM $0.645 $3.670 risen by 468.99%
$2,210 Application for quotation of securities - 4DX 18 Jul 2022 9:05AM $0.490 $3.670 risen by 648.98%
$2,210 Release of restricted securities from escrow 18 Jul 2022 9:01AM $0.490 $3.670 risen by 648.98%
$2,210 Notification of cessation of securities - 4DX 11 Jul 2022 4:24PM $0.535 $3.670 risen by 585.98%
$2,210 4DMedical secures national contract with I-MED 28 Jun 2022 10:23AM $0.390 $3.670 risen by 841.03%
$2,210 4DMedical appoints experienced MedTech CFO 24 Jun 2022 8:29AM $0.355 $3.670 risen by 933.80%
$2,210 Board Change - Executive Appointment 23 May 2022 4:02PM $0.610 $3.670 risen by 501.64%
$2,210 4DMedical clinical trial results presented at ATS 16 May 2022 8:24AM $0.755 $3.670 risen by 386.09%
$2,210 Quarterly Activity Report and Appendix 4C for Q3 FY2022 29 Apr 2022 9:31AM $0.705 $3.670 risen by 420.57%

451 - 475 of 610 results

Page 19 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.